期刊文献+

多种临床指标联合应用在射血分数降低型和保留型急性心力衰竭鉴别诊断中的价值 被引量:2

The value of combination of several clinic indicators in the differential diagnose of acute heart failure with reduced ejection fraction and preserved ejection fraction
原文传递
导出
摘要 目的探讨就诊时年龄、血压、心率、氨基末端脑钠肽前体(NT-pro BNP)等指标的联合应用在鉴别诊断射血分数(EF)降低型急性心力衰竭(AHFREF)和EF保留型急性心力衰竭(AHFPEF)中的价值。方法回顾性分析急性心力衰竭(AHF)患者就诊时年龄、性别、血压、心率、NT-pro BNP、微机血糖及1 d内心脏超声等指标。将AHF患者分为AHFREF组(EF<0.5)和AHFPEF组(EF≥0.5)。用二分类Logistic回归分析建立回归方程。根据接受者工作特征(ROC)曲线选择最适诊断截点。结果入选患者130例,年龄[M(P25,P75)]74.0(64.0,80.0)岁,男79例(60.8%),女51例(39.2%)。AHFREF组50例(38.5%),AHFPEF组80例(61.5%)。X1(NT-pro BNP)、X2(收缩压)、X3(舒张压)、X4(年龄)、X5(心率)进入回归方程P=1/[1+e-(-1.432+0.524X1-0.023X2+0.038X3-0.029X4+0.012X5)],最适诊断截点0.345,准确度为76.9%,灵敏度为84.0%,特异度为72.5%。结论联合应用就诊时年龄、血压、心率、NT-pro BNP对鉴别诊断AHFREF和AHFPEF有重要的参考价值。 Objective To study the value of combination of several clinic indicators [age, blood pressure(BP), heart rate(HR), N terminal pro brain natriuretic peptide(NT-pro BNP)] in the differential diagnose of acute heart failure(AHF) with reduced ejection fraction(EF) and preserved ejection fraction(AHFREF, AHFPEF). Methods Age, BP, HR, NTpro BNP, blood glucose at admission, and cardiac ultrasonic inspection indicators in 24 hours after admission of patients with AHF were analyzed retrospectively. Patients with AHF were divided into AHFREF group(EF 50%) and AHFPEF group(EF ≥50%). The regression equation was created by binary logistic regression analysis. The optimal truncation point was selected by the receiver operator characteristic curve(ROC). Results 130 patients with AHF were enrolled, age M(P25,P75)74.0(64.0,80.0)years old, men 79(60.8%), women 51(43.8%). AHFREF group(n=50,38.5%), AHFPEF group(n=80,61.5%). X1(NT-pro BNP), X2(systolic blood pressure, SBP), X3(diastolic blood pressure, DBP), X4(age)and X5(HR)were elected into the regression equation P =1 / [1 +e^-(-1.432 +0.524X1-0.023X2 +0.038X3-0.029X4 +0.012X5)]. The optimal truncation point was0.345, with accuracy 76.9%, sensitivity 84.0%, and specificity 72.5%. Conclusion There is significant reference value of combination of age, BP, HR with NT-pro BNP at admission in the differential diagnose of AHFREF and AHFPEF.
出处 《热带医学杂志》 CAS 2015年第1期66-69,共4页 Journal of Tropical Medicine
基金 中山市市科技立项(20122A179)
关键词 血压 氨基末端脑钠肽前体 射血分数 急性心力衰竭 blood pressure N terminal pro brain natriuretic peptide ejection fraction acute heart failure
  • 相关文献

参考文献15

  • 1Fonarow GC,Stough WG,Abraham WT,et al.Characteristics,treatments,and outcomes of patients with preserved systolic function hospitalized for heart failure:a report from the OPTIMIZE-HF Registry[J].J Am Coll Cardiol,2007,50(8):768-777.
  • 2Owan TE,Redfield MM.Epidemiology of diastolic heart failure[J].Prog Cardiovasc Dis,2005,47(5):320-332.
  • 3Lam C,Donal E,Kraigher-Krainer E,et al.Epidemiology and clinical course of heart failure with preserved ejection fraction[J].Eur J Heart Fail,2011,13(1):18-28.
  • 4Januzzi JL,Camargo CA,Anwaruddin S,et al.The N-terminal Pro-BNP investigation of dyspnea in the emergency department(PRIDE)study[J].Am J Cardiol,2005,95(8):948-954.
  • 5Januzzi JL,van Kimmenade R,Lainchbury J,et al.NT-pro BNP testing for diagnosis and short-term prognosis in acute destabilized heart failure:an international pooled analysis of 1256 patients.The International Collaborative of NT-pro BNP Study[J].Eur Heart J,2006,27(3):330-337.
  • 6Chen AA,Wood MJ,Krauser DG,et al.NT-pro BNP levels,echocardiographic findings,and outcomes in breathless patients:results from the Pro BNP Investigation of Dyspnoea in the Emergency Department(PRIDE)echocardiographic substudy[J].Eur Heart J,2006,27(7):839-845.
  • 7Tsch觟pe C,Kasner M,Westermann D,et al.The role of NTpro BNP in the diagnostics of isolated diastolic dysfunction:correlation with echocardiographic and invasive measurements[J].Eur Heart J,2005,26(21):2277-2284.
  • 8Tsch觟pe C,Kasner M,Westermann D,et al.Elevated NTPro BNP levels in patients with increased left ventricular filling pressure during exercise despite preserved systolic function[J].J Card Fail,2005,11(Suppl):S28-S33.
  • 9赵雅琳,姚宇.舒张性与收缩性心力衰竭N末端心房利钠肽前体和N末端脑钠肽前体的研究[J].中华老年心脑血管病杂志,2011,13(8):722-723. 被引量:11
  • 10潘三葱,秦中胜,崔花花,张卫玲,孙玉霞.收缩性心力衰竭和舒张性心力衰竭患者血浆N末端B型利钠肽原的对比分析及与年龄的关系[J].中华老年多器官疾病杂志,2013,12(6):447-449. 被引量:3

二级参考文献34

  • 1Fox K, Ford I, Steg PG, et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial[J]. Lancet, 2008, 372(9641):817- 821.
  • 2La Rovere MT, Pinna GD, Maestri R, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients[J]. Circulation, 2003,107(4): 565-570.
  • 3Bangalore S, Sawhney S, Messerli FH. Relation of beta blocker induced heart rate lowering and cardioprotection in hypertension[J]. J Am Coil Cardiol, 2008, 52 (18): 1482- 1489.
  • 4Communal C, Singh K, Sawyer DB, et al. Opposing effects of beta ( 1 ) and beta (2)-adrenergic receptors on cardiac myocyte apoptosis : role of a pertussis toxin-sensitive G protein. [J]. Circulation,1999, 100(22) :2210-2212.
  • 5Thackray SD, Ghosh JM, Wright GA, et al. The effect of altering heart rate on ventricular function in patients with heart failure treated with beta bloekers[J]. Am Heart J, 2006, 152(4):713. e9-e13.
  • 6Saba MM, Ibrahim MM, Riszk HH. Gender and the relationship between resting heart rate and left ventricular geometry[J]. J Hypertens,2001, 19(3):367- 373.
  • 7Lechat P, Escolano S, Golmard JL, et al. Prognostic value of bisoprolol induced hemodynamic effects in heart failure during the Cardiac Insufficiency Blsoprolol Study (CIBIS) [ J ]. Circulation, 1997, 96(7) :2197 -2205.
  • 8Lechat P, Hulot J-S, Escolano S, et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial[J]. Circulation, 2001,103(10) :1428- 1433.
  • 9Dobre D, van Veldhuisen DJ, Goulder MA, et al. Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS Ⅲ Trial[J]. Cardiovasc Drugs Ther, 2008, 22(5)=399 405,.
  • 10Mulder P, Barbier S, Chagraoui A, et al. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure[J]. Circulation,2(/04,109(13):1674 -1679.

共引文献19

同被引文献23

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部